pharmaceutical daily

Arrhythmias Pipeline Review, H1 2019 –

– Pipeline Review, H1 2019”
report has been added to’s

This latest pipeline guide Arrhythmias – Pipeline Review, H1 2019,
provides comprehensive information on the therapeutics under development
for Arrhythmias (Cardiovascular), complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The guide covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases.

The Arrhythmias (Cardiovascular) pipeline guide also reviews of key
players involved in therapeutic development for Arrhythmias and features
dormant and discontinued projects. The guide covers therapeutics under
Development by Companies /Universities /Institutes, the molecules
developed by Companies in Phase I, Preclinical and Discovery stages are
1, 11 and 2 respectively. Similarly, the Universities portfolio in
Preclinical and Discovery stages comprises 3 and 1 molecules,

Arrhythmias (Cardiovascular) pipeline guide helps in identifying and
tracking emerging players in the market and their portfolios, enhances
decision making capabilities and helps to create effective counter
strategies to gain competitive advantage. The guide is built using data
and information sourced from the researcher’s proprietary databases,
company/university websites, clinical trial registries, conferences, SEC
filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources.
Additionally, various dynamic tracking processes ensure that the most
recent developments are captured on a real time basis.


Reasons to buy

Companies Mentioned

For more information about this report visit

About is the world’s leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.

Laura Wood, Senior Press Manager
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Topics: Women’s

Exit mobile version